Search

Your search keyword '"Akarca, Ayse"' showing total 148 results

Search Constraints

Start Over You searched for: Author "Akarca, Ayse" Remove constraint Author: "Akarca, Ayse" Search Limiters Full Text Remove constraint Search Limiters: Full Text
148 results on '"Akarca, Ayse"'

Search Results

1. Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models

4. ConCORDe-Net: Cell Count Regularized Convolutional Neural Network for Cell Detection in Multiplex Immunohistochemistry Images

5. Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma

6. Geospatial immune variability illuminates differential evolution of lung adenocarcinoma

7. Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress

11. Impact of MYC and BCL2 double expression on outcomes in primary CNS lymphoma: a UK multicenter analysis

12. Correction to: Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program

13. Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program

14. CD47 expression in acute myeloid leukemia varies according to genotype

15. Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer

16. Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma

17. Targeting the T cell receptor [beta]-chain constant region for immunotherapy of T cell malignancies

18. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

19. Impact of Double Expression of MYC and BCL-2 on Outcomes in Primary CNS Lymphoma: A UK Multicentre Analysis

21. Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast Cancers

22. Abstract 3096: Multi-region patient-derived xenograft models from non-small cell lung cancer patients enrolled in lung TRACERx

23. Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors

24. Correction to: Single‑cell profiling of myasthenia gravis identifies a pathogenic T cell signature

25. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

26. Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

27. Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy.

28. Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution

30. Induction of APOBEC3 exacerbates DNA replication stress and chromosomal instability in early breast and lung cancer evolution

31. Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution

32. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature

33. Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma

34. The lifespan and kinetics of human dendritic cell subsets and their precursors in health and inflammation

35. Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression

36. Megakaryocytes, erythropoietic and granulopoietic cells express CAL2 antibody in myeloproliferative neoplasms carrying CALR gene mutations

37. Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4+ T Cells

38. Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response

40. Role of Epstein-Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature

41. Hypoxic adaptation of leukemic cells infiltrating the CNS affords a therapeutic strategy targeting VEGFA

42. Megakaryocytes, erythropoietic and granulopoietic cells express CAL2 antibody in myeloproliferative neoplasms carrying CALR gene mutations.

43. Cytotoxic CD4+ Cells in Chronic Lymphocytic Leukaemia: An Extended Immunophenotypic Analysis Examining Their Association with Cytomegalovirus Serostatus and Similarities with Cytotoxic CD8+ Cells

44. Erratum: Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

45. Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies

46. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade

47. VEGFA- a New Therapeutic Target in CNS Leukemia

49. ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer–Containing Antibody–Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies

50. Mechanistic and Pharmacodynamic Studies of Adct-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies

Catalog

Books, media, physical & digital resources